SPY417.26+1.39 0.33%
DIA341.86+1.53 0.45%
IXIC14,052.34+13.58 0.10%

Cogent Biosciences Q4 Sales $7.87M Down From $22.50M YoY

Cogent Biosciences (NASDAQ:COGT) reported $7.87 million in sales this quarter. This is a 65.02 percent decrease over sales of $22.50 million the same period last year.

· 03/16/2021 07:19
Cogent Biosciences (NASDAQ:COGT) reported $7.87 million in sales this quarter. This is a 65.02 percent decrease over sales of $22.50 million the same period last year.